Yer absolutely. So they have done IV phase 1 testing on sepsis that provided ample data to move forward to a phase 2 trial for sepsis or urosepsis/UTI. However, they have chosen to start the UTI at phase 1 to work on dosing. What they haven't disclosed and what we can infer, is based on the plasma concentration readouts from the phase 1 sepsis, they are desperate to increase concentration levels or 327 will be ineffective in the blood stream. This is why they are still tinkering with dosing.
This is also one reason people get annoyed, the dishonesty. In an interview they said the plasma concentrations from the original trials are fine, yet their own data from in vivo and vitro tests shows they are not anywhere near enough to kill the bacteria, and spending more time working on dosing in phase 1 trials just confirms this. You may also find if they are true to old form that sepsis just disappears from all mention over coming months.
- Forums
- ASX - By Stock
- Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
Yer absolutely. So they have done IV phase 1 testing on sepsis...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
64.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $130.5M |
Open | High | Low | Value | Volume |
65.0¢ | 65.0¢ | 64.0¢ | $7.617K | 11.77K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5474 | 64.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
65.0¢ | 3055 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24689 | 0.635 |
1 | 30000 | 0.630 |
1 | 12099 | 0.610 |
5 | 10586 | 0.600 |
1 | 9899 | 0.585 |
Price($) | Vol. | No. |
---|---|---|
0.650 | 3055 | 2 |
0.655 | 11456 | 1 |
0.660 | 42822 | 4 |
0.665 | 37329 | 1 |
0.670 | 100000 | 1 |
Last trade - 10.52am 06/05/2024 (20 minute delay) ? |
|
|||||
Last
65.0¢ |
  |
Change
0.000 ( 1.56 %) |
|||
Open | High | Low | Volume | ||
65.0¢ | 65.0¢ | 65.0¢ | 1540 | ||
Last updated 11.16am 06/05/2024 ? |
Featured News
RCE (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online